Atalanta Therapeutics
atalantatx.comLocations
Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology · DeepTech
Size
51-200 employees
Stage
Series B
founded in
2018
Atalanta Therapeutics is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases through its proprietary RNA interference technology. The company aims to halt diseases like Huntington's at their source, leveraging groundbreaking discoveries in gene silencing. With a strong foundation in scientific research and a commitment to addressing urgent medical needs, Atalanta is positioned to make significant contributions to the field of CNS therapeutics, targeting a critical market with high demand for effective interventions.
Something looks off?Open jobs at Atalanta Therapeutics
On-site & Remote
Job function
Seniority
Salary